dual glp 1 glucagon receptor agonists The Emerging Role of GLP-1 and GIP in Glycemic Management and Cardiovascular Risk Reduction The dual agonist action of

GI, Gastrointestinal

A., Kaelber, D

Participants self-reported their ethnic backgrounds into categories such as White, Mixed, Asian or Asian British, Black or Black British, and Other ethnic groups, with the majority (~94%) identifying as White British

The scans were conducted by a clinical scientist and trained radiographer

Common GLP-1 drugs include: Semaglutide (Ozempic, Wegovy, Rybelsus) Liraglutide (Victoza, Saxenda) Dulaglutide (Trulicity) Exenatide (Byetta, Bydureon) These drugs improve insulin resistance , aid in weight loss , and now appear to reduce inflammation , offering benefits far beyond diabetes

Triple board-certified weight loss physician Dr